ストックスクリーナーアプリを入手
5.23
9.64%
0.46
プレマーケット:
5.30
0.07
+1.34%
Maravai Lifesciences Holdings Inc (MRVI) 最新ニュース
Maravai LifeSciences Holdings, Inc. (MRVI) Stock: An Under $5 Gem with Biggest Upside Potential - Yahoo Finance
12 Stocks Under $5 With Biggest Upside Potential - Insider Monkey
Maravai LifeSciences (NASDAQ:MRVI) Shares Gap UpTime to Buy? - MarketBeat
Are Investors Undervaluing Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) By 43%? - Simply Wall St
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Shares Bought by Barclays PLC - Defense World
How the (MRVI) price action is used to our Advantage - Stock Traders Daily
Maravai LifeSciences Holdings (STU:MAR) Other Stockholders Equity : €0.0 Mil (As of Sep. 2024) - GuruFocus.com
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Rating of “Hold” by Analysts - Defense World
Maravai LifeSciences (NASDAQ:MRVI) Stock Price Down 15.7%Here's What Happened - MarketBeat
Maravai LifeSciences projects FY revenue near mid-range guidance; shares fall - Investing.com Australia
Maravai LifeSciences Sees Unusually High Options Volume (NASDAQ:MRVI) - Defense World
Stock Traders Buy High Volume of Maravai LifeSciences Put Options (NASDAQ:MRVI) - MarketBeat
Maravai Lifesciences Holdings, Inc. Eliminates Andrew Burch as President, Nucleic Acid Production - Marketscreener.com
Maravai LifeSciences Holdings Projects 2024 Revenue Near Midpoint of Guidance - MarketWatch
Maravai LifeSciences Restructures Leadership Amid Revenue Update - TipRanks
Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue - The Manila Times
Maravai LifeSciences (MRVI) Announces In-Line Preliminary 2024 Revenue - StreetInsider.com
Maravai LifeSciences Expects 2024 Revenue to Hit Mid-Range of $255-265M Guidance - StockTitan
JPMorgan Chase & Co. Raises Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
JPMorgan Chase & Co. Has $33.66 Million Stock Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Jane Street Group LLC Sells 201,787 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Shares Sold by Jane Street Group LLC - MarketBeat
Principal Financial Group Inc. Reduces Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Principal Financial Group Inc. Has $2.93 Million Stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
Franklin Resources Inc. Takes $600,000 Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Shares Acquired by Barclays PLC - Defense World
Geode Capital Management LLC Raises Stock Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
Geode Capital Management LLC Grows Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Maravai LifeSciences (NASDAQ:MRVI) Shares Gap DownHere's What Happened - MarketBeat
Investors Buy High Volume of Maravai LifeSciences Put Options (NASDAQ:MRVI) - Defense World
State Street Corp Sells 16,338 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Objective long/short (MRVI) Report - Stock Traders Daily
Maravai Lifesciences initiated with a Neutral at Guggenheim - Yahoo Finance
MRVI Stock Drops 5% Amidst Biotech Sector Decline - GuruFocus.com
Guggenheim starts Maravai LifeSciences stock with neutral rating - Investing.com
Danaher, Cryoport, Sartorius win Buy at Guggenheim (DHR:NYSE) - Seeking Alpha
Guggenheim starts Maravai LifeSciences stock with neutral rating By Investing.com - Investing.com UK
Guggenheim Initiates Coverage on Maravai LifeSciences (NASDAQ:MRVI) - MarketBeat
Exploring December 2024's Undervalued Small Caps With Insider Action In US - Simply Wall St
Maravai LifeSciences reduces debt by $228 million - Investing.com Australia
Maravai LifeSciences reduces debt by $228 million By Investing.com - Investing.com South Africa
Maravai LifeSciences (NASDAQ:MRVI) Stock Price Down 4.8%Time to Sell? - MarketBeat
Maravai LifeSciences (NASDAQ:MRVI) Trading Up 3.8%Here's Why - MarketBeat
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of “Hold” by Brokerages - Defense World
Maravai LifeSciences' SWOT analysis: stock outlook amid mRNA manufacturing expansion - Investing.com
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $1.71 Million Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
The Manufacturers Life Insurance Company Has $490,000 Stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Traders Purchase Large Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI) - MarketBeat
Charles Schwab Investment Management Inc. Has $7.87 Million Stock Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Maravai LifeSciences' SWOT analysis: stock faces challenges amid growth potential - Investing.com Nigeria
Quantinno Capital Management LP Buys 289,141 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
4.81%
大文字化:
|
ボリューム (24 時間):